Overview Financials News + Filings Key Docs Insiders |
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 0.0 | 0.2 | 0.3 | 0.4 | 0.1 | 0.1 | 1.6 | 1.5 |
Revenue growth | -98.9% | -38.7% | -22.2% | 203.1% | -7.9% | -91.3% | 10.1% | 10.0% |
Cost of goods sold | 0.0 | 0.0 | 0.9 | 1.7 | 2.5 | 1.6 | 0.5 | 0.5 |
Gross profit | 0.0 | 0.2 | -0.6 | -1.3 | -2.4 | -1.5 | 1.1 | 0.9 |
Gross margin | 100.0% | 100.0% | -187.7% | -343.6% | -1887.5% | -1060.4% | 70.4% | 64.8% |
Selling, general and administrative | | | | | | | | |
Sales and marketing | | | | | | | | 2.3 |
Research and development | 0.0 | 0.0 | | 0.7 | 1.7 | 1.2 | | |
General and administrative | 2.8 | 2.5 | 0.4 | 3.9 | 6.1 | 4.0 | 7.6 | 5.1 |
EBITA | -2.9 | -2.3 | -1.0 | -5.5 | -15.6 | -5.2 | -4.0 | -4.2 |
EBITA margin | -145600.0% | -1254.6% | -320.9% | -1429.9% | -12202.3% | -3772.7% | -249.3% | -288.8% |
Amortization of intangibles | 0.0 | | | | 0.0 | | | |
EBIT | -2.9 | -2.3 | -1.0 | -5.5 | -15.6 | -5.2 | -4.0 | -4.2 |
EBIT margin | -145750.0% | -1254.6% | -320.9% | -1429.9% | -12207.0% | -3772.7% | -249.3% | -288.8% |
Pre-tax income | -6.0 | -3.1 | -1.7 | -7.1 | -15.6 | -9.3 | -6.6 | 3.2 |
Income taxes | 0.0 | 0.0 | 0.2 | 0.0 | 0.1 | 0.0 | 2.3 | 1.0 |
Tax rate | 0.0% | 0.0% | | 0.0% | | | | 32.2% |
Earnings from continuing ops | -5.8 | -2.9 | -1.7 | -7.1 | -15.6 | -9.3 | -6.6 | 2.2 |
Earnings from discontinued ops | -0.1 | -0.1 | -0.2 | 0.0 | -0.1 | 0.0 | -2.3 | |
Net income | -6.0 | -3.1 | -2.0 | -7.1 | -15.8 | -9.4 | -8.9 | 2.2 |
Net margin | -298050.0% | -1652.4% | -650.7% | -1832.2% | -12324.2% | -6743.2% | -560.1% | 151.0% |
|
Diluted EPS | ($0.03) | ($0.01) | ($0.01) | ($0.04) | ($0.09) | ($0.06) | ($0.04) | $0.01 |
Shares outstanding (diluted) | 221.3 | 203.8 | 199.9 | 193.5 | 166.4 | 154.1 | 152.3 | 164.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|